1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 1: 
Patient clinical data
Pathologies (No. of Patients and Average Tumor Size)Skull Base DefectsESBR Tissues (No. of Patients)Length of MRI Follow-Up (mo)Adjuvant Therapy (No. of Patients)
Esthesioneuroblastoma (n = 6; 2.5 cm)ASBF, FL, NSF, FM (n = 1)9–32Radiation (n = 4),
D, NSF (n = 3)Chemoradiation (n = 2)
D, NSF, FM (n = 2)
Sinonasal endocrine carcinoma (n = 1; 4.0 cm)ASBF, FL, NSF, FM (n = 1)16Chemoradiation (n = 1)
Sinonasal undifferentiated carcinoma (n = 1; 2.2 cm)ASBD, NSF (n = 1)3Chemoradiation (n = 1)
Chondrosarcoma (n = 1; 2.5 cm)ClivusD, NSF (n = 1)21Radiation (n = 1)
Chordoma (n = 3; 2.0 cm)ClivusNSF (n = 2)9–21Radiation (n = 2)
F, FL, NSF (n = 1)
Meningioma (n = 4; 2.2 cm)ASBD, NSF (n = 1)3–41Radiation (n = 1)
CSBF, FL, NSF (n = 2)
ClivusF, FL, NSF (n = 1)
Craniopharyngioma (n = 1; 3.5 cm)CSBF, FL, NSF (n = 1)6
Pituicytoma (n = 1; 3.1 cm)CSBF, FL, NSF (n = 1)13Radiation (n = 1)
Pituitary macroadenoma (n = 4; 3.4 cm)CSBNSF (n = 1)6–27Radiation (n = 1)
F, NSF (n = 1)
FL, NSF (n = 1)
F, FL, NSF (n = 1)
  • Note:—ASB indicates cribriform plates, crista galli, and/or ethmoid fovealis; CSB, planum sphenoidale, tuberculum sella, sella, and/or dorsum sella; D, collagen matrix dural graft; F, intracranial fat; FL, fascia lata; FM, free mucosa.